Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Impact of study design on the results of continuation studies of antidepressants.

Zimmerman M, Posternak MA, Ruggero CJ.

J Clin Psychopharmacol. 2007 Apr;27(2):177-81.

PMID:
17414242
2.

Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial.

Kornstein SG, Bose A, Li D, Saikali KG, Gandhi C.

J Clin Psychiatry. 2006 Nov;67(11):1767-75.

PMID:
17196058
3.

Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

Perahia DG, Wang F, Mallinckrodt CH, Walker DJ, Detke MJ.

Eur Psychiatry. 2006 Sep;21(6):367-78. Epub 2006 May 11.

PMID:
16697153
4.

Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial.

Lustman PJ, Clouse RE, Nix BD, Freedland KE, Rubin EH, McGill JB, Williams MM, Gelenberg AJ, Ciechanowski PS, Hirsch IB.

Arch Gen Psychiatry. 2006 May;63(5):521-9.

PMID:
16651509
5.

Maintenance treatment of major depression in old age.

Reynolds CF 3rd, Dew MA, Pollock BG, Mulsant BH, Frank E, Miller MD, Houck PR, Mazumdar S, Butters MA, Stack JA, Schlernitzauer MA, Whyte EM, Gildengers A, Karp J, Lenze E, Szanto K, Bensasi S, Kupfer DJ.

N Engl J Med. 2006 Mar 16;354(11):1130-8.

6.

Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder.

Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS.

Ann Intern Med. 2005 Sep 20;143(6):415-26. Review.

PMID:
16172440
7.
8.

A randomized, placebo-controlled trial of sertraline for prophylactic treatment of highly recurrent major depressive disorder.

L├ępine JP, Caillard V, Bisserbe JC, Troy S, Hotton JM, Boyer P.

Am J Psychiatry. 2004 May;161(5):836-42. Erratum in: Am J Psychiatry. 2004 Jul;161(7):1320.

PMID:
15121648
9.

Venlafaxine versus placebo in the preventive treatment of recurrent major depression.

Montgomery SA, Entsuah R, Hackett D, Kunz NR, Rudolph RL; Venlafaxine 335 Study Group.

J Clin Psychiatry. 2004 Mar;65(3):328-36.

PMID:
15096071
10.

Extended-release venlafaxine in relapse prevention for patients with major depressive disorder.

Simon JS, Aguiar LM, Kunz NR, Lei D.

J Psychiatr Res. 2004 May-Jun;38(3):249-57. Erratum in: J Psychiatr Res. 42004 Jul-Aug;38(4):51.

PMID:
15003430
11.

Escitalopram continuation treatment prevents relapse of depressive episodes.

Rapaport MH, Bose A, Zheng H.

J Clin Psychiatry. 2004 Jan;65(1):44-9.

PMID:
14744167
12.

Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.

Gelenberg AJ, Trivedi MH, Rush AJ, Thase ME, Howland R, Klein DN, Kornstein SG, Dunner DL, Markowitz JC, Hirschfeld RM, Keitner GI, Zajecka J, Kocsis JH, Russell JM, Miller I, Manber R, Arnow B, Rothbaum B, Munsaka M, Banks P, Borian FE, Keller MB.

Biol Psychiatry. 2003 Oct 15;54(8):806-17.

PMID:
14550680
13.
15.

Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review.

Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, Goodwin GM.

Lancet. 2003 Feb 22;361(9358):653-61. Review.

PMID:
12606176
16.

Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy.

Klysner R, Bent-Hansen J, Hansen HL, Lunde M, Pleidrup E, Poulsen DL, Andersen M, Petersen HE.

Br J Psychiatry. 2002 Jul;181:29-35.

17.

Continuation phase treatment with bupropion SR effectively decreases the risk for relapse of depression.

Weihs KL, Houser TL, Batey SR, Ascher JA, Bolden-Watson C, Donahue RM, Metz A.

Biol Psychiatry. 2002 May 1;51(9):753-61.

PMID:
11983189
18.

Efficacy of mirtazapine for prevention of depressive relapse: a placebo-controlled double-blind trial of recently remitted high-risk patients.

Thase ME, Nierenberg AA, Keller MB, Panagides J; Relapse Prevention Study Group.

J Clin Psychiatry. 2001 Oct;62(10):782-8.

PMID:
11816867
19.

Fluoxetine in the prevention of depressive recurrences: a double-blind study.

Gilaberte I, Montejo AL, de la Gandara J, Perez-Sola V, Bernardo M, Massana J, Martin-Santos R, Santiso A, Noguera R, Casais L, Perez-Camo V, Arias M, Judge R; Fluoxetine Long-Term Study Group.

J Clin Psychopharmacol. 2001 Aug;21(4):417-24.

PMID:
11476126
20.

Current methods of the US Preventive Services Task Force: a review of the process.

Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, Atkins D; Methods Work Group, Third US Preventive Services Task Force.

Am J Prev Med. 2001 Apr;20(3 Suppl):21-35.

PMID:
11306229

Supplemental Content

Support Center